Daratumumab

Trade Name: 
Darzalex SC
Manufacturer/Distributor: 
Janssen Inc.
Classification: 
Antineoplastic agent, monoclonal antibody
ATC Class: 
L01CX24 - daratumumab
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2020/08/12
Date Marketed in Canada (yyyy/mm/dd): 
2020/08/12
Presentation: 
Solution for S/C injection: 120 mg/mL. DIN: 02502712
Comments: 
For treatment of multiple myeloma (see product monograph for specifics).